Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
Brigatinib represents a significant leap forward in personalized cancer treatment, acting as a powerful ALK inhibitor. This small molecule drug has shown considerable promise in managing specific types of non-small cell lung cancer (NSCLC), particularly those characterized by an ALK gene rearrangement. As a dedicated supplier of pharmaceutical intermediates, our role is to ensure that this critical component is available in high purity and quality to support the pharmaceutical industry's efforts in developing effective cancer therapies.
The mechanism of Brigatinib is central to its therapeutic value. By inhibiting the ALK protein, it effectively disrupts the signaling pathways that drive the growth and proliferation of cancer cells in ALK-positive NSCLC. This targeted approach distinguishes it from traditional chemotherapy, offering a more precise intervention. The availability of Brigatinib as an API (Active Pharmaceutical Ingredient) is therefore crucial for pharmaceutical companies and research institutions working on the forefront of oncology. Our expertise as a supplier of ALK inhibitor intermediates from China is geared towards meeting these exacting demands.
We provide Brigatinib API with a purity exceeding 98%, ensuring it meets the stringent pharmaceutical grade requirements essential for drug development and manufacturing. The compound is supplied in a stable powder form, with a shelf life of two years, facilitating its integration into various production processes. This commitment to quality assurance is paramount, as the efficacy and safety of the final medicinal product are directly dependent on the quality of the raw materials used. Our position as a reliable source for this key pharmaceutical intermediate allows our clients to proceed with their vital work with confidence.
The application of Brigatinib API extends to enabling continued research into ALK-driven cancers and exploring its potential in combination therapies. By sourcing our high-purity Brigatinib, pharmaceutical companies can advance their pipelines and bring innovative treatments to patients who need them most. As a leading supplier of ALK inhibitor pharmaceutical intermediates in China, we are dedicated to supporting the global fight against cancer by providing essential, high-quality chemical building blocks like Brigatinib.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
